Diabetes and the Heart: Is There Objective Evidence of a Human Diabetic Cardiomyopathy?
Year: 2013
Type: article
Abstract: The concept of a “diabetic cardiomyopathy ” hasbeen invoked to explain the higher than expectedoccurrence of congestive heart failure (CHF)in subjects with diabetes (1,2). However, the evidence supporting the existence of such a condition in humans is mostly inferential. Cardiomyopathies are chronic diseases of the myocardium in which the heart is abnor-mally enlarged, thickened, and/or stiffened. The weakened heart muscle has a reduced ability to pump blood effec-tively. Diabetic cardiomyopathy is frequently considered to be present when there is any abnormality of myocardial diastolic or systolic function, even when very mild, in a di-abetic subject (or animal) without known hypertension or coronary artery disease. Isolated metabolic or biochemical abnormalities in the heart have also been taken as evidence of this entity. It has been referred to as a “specific ” cardio-myopathy that may include features such as left ventricular (LV) hypertrophy, myocardial fibrosis, altered myocardial
Source: Diabetes
DOI: 10.2337/db13-0683
Author: Sheldon E. Litwin
Institution: Augusta University
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W2104379002
